Integrated Mendelian Randomization and Single‐Cell Transcriptomics Analysis Identifies Critical Blood Biomarkers and Potential Mechanisms in Epilepsy
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70172 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Jianwei Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Epilepsy, Mendelian Randomization Analysis, Biomarkers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Health Commission.
Abstract (Originalsprache)
Background
Epilepsy has a genetic predisposition, yet causal factors and the dynamics of the immune environment in epilepsy are not fully understood.
Methods
We analyzed peripheral blood samples from epilepsy patients, identifying key genes associated with epilepsy risk through Mendelian randomization, using eQTLGen and genome‐wide association studies. The peripheral immune environment's composition in epilepsy was explored using CIBERSORT. An epilepsy mouse model was established to validated the expression of key genes at the transcriptomic and proteomic levels through single‐cell analysis. Relevant pathways were verified. Finally, we developed a predictive model for antiepileptic drug response in epilepsy patients.
Results
We found that CDC25B , DNMT1 , GZMA , MTX1 , and SSH2 expression decreases epilepsy risk, whereas FGD3 , RAF1 , and SH3BP5L increase it. Epilepsy patients exhibited an altered peripheral immune profile, notably with increased activated mast cells and decreased CD4 memory activated T cells and γδ T cells. Eight genes were significantly related to this immune environment. In the animal model, FGD3 , SSH2 , and DNMT1 were upregulated at both mRNA and protein levels in the hippocampus. FGD3 and SSH2 are specifically elevated in microglia and are primarily associated with actin regulation. The trained predictive model was deployed on an online platform.
Conclusions
This study elucidates key genes linked to epilepsy, delineates the epilepsy immune landscape, and highlights the interaction between these domains, providing insights into potential epilepsy mechanisms and treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
- China International Neuroscience Institute, Beijing, China.
- Deanery of Biomedical Sciences, Edinburgh Medical School, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
- National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Department of Neurosurgery, First Hospital of Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Jianwei Shi, Ting Tang, Penghu Wei, Yongzhi Shan, Guoguang Zhao
Förderung
- National Natural Science Foundation of China
- Beijing Municipal Health Commission
Zitieren
APA
Shi, J., Xie, J., Yang, Y., Fu, B., Ye, Z., Tang, T., Liu, Q., Xu, J., Wei, P., Shan, Y., & Zhao, G. (2025). Integrated Mendelian Randomization and Single‐Cell Transcriptomics Analysis Identifies Critical Blood Biomarkers and Potential Mechanisms in Epilepsy. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70172
Vancouver
Shi J, Xie J, Yang Y, Fu B, Ye Z, Tang T, et al. Integrated Mendelian Randomization and Single‐Cell Transcriptomics Analysis Identifies Critical Blood Biomarkers and Potential Mechanisms in Epilepsy. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70172
BibTeX
@article{Shi2025,
author = {Shi, Jianwei and Xie, Jing and Yang, Yanfeng and Fu, Bin and Ye, Zuliang and Tang, Ting and Liu, Quanlei and Xu, Jinkun and Wei, Penghu and Shan, Yongzhi and Zhao, Guoguang},
title = {Integrated Mendelian Randomization and Single‐Cell Transcriptomics Analysis Identifies Critical Blood Biomarkers and Potential Mechanisms in Epilepsy},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70172}
}
EUVIMED